Science Explorer Back to mapMap
Discussion
Researcher · Bugando Medical Centre · Tanzania

Samuel Elias Kalluvya

Samuel Elias Kalluvya publishes mostly in Infectious Diseases, Epidemiology and Emergency Medicine, on topics such as HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions and HIV-related health complications and treatments.

ORCID 0000-0002-2582-2081 OpenAlex
World rank
#3,224,063
of 7,710,434 ranked researchers
Rank in Tanzania
#1,718
of 3,522
Works
53
Citations
948
Citations per work
17.9
h-index
17
i10-index 19Top 32% in Infectious Diseases
Samuel Elias Kalluvya

What does Samuel Elias Kalluvya research?

Samuel Elias Kalluvya's work is mostly in Medicine (52%), Immunology and Microbiology (5%), Health Professions (5%).

Health Sciences: 30 works · 56.9% of their workMedicine: 28 works · 52.3% of their workInfectious Diseases: 11 works · 19.9% of their workEpidemiology: 10 works · 19.2% of their workEmergency Medicine: 5 works · 8.6% of their workHepatology: 2 works · 4.6% of their workHealth Professions: 2 works · 4.6% of their workGeneral Health Professions: 2 works · 4.6% of their workEverything else: 20 works · 37.8% of their workLife Sciences: 3 works · 5.3% of their workImmunology and Microbiology: 3 works · 5.3% of their workVirology: 3 works · 5.3% of their workTHEIR WORKSamuel EliasKalluvya53works
Life Sciences5%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2852.3%
    2. Health Professions24.6%
  2. Everything else2037.8%
    1. Immunology and Microbiology35.3%
  1. 1Infectious Diseases20% of their works
  2. 2Epidemiology19% of their works
  3. 3Emergency Medicine9% of their works
  4. 4Virology5% of their works
  5. 5Hepatology5% of their works
  6. 6General Health Professions5% of their works

Research topics

Which keywords describe Samuel Elias Kalluvya's research?

The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, HIV, Immune Response, Drug Resistance, Integrase Inhibitors, Antifungal Therapy and Epidemiology.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Antiretroviral Therapy414 topics
  2. HIV Infection222 topics
  3. HIV142 topics
  4. Immune Response132 topics
  5. Drug Resistance121 topic
  6. Integrase Inhibitors121 topic
  7. Antifungal Therapy112 topics
  8. Epidemiology112 topics
  9. HIV Transmission111 topic
  10. Preexposure Prophylaxis111 topic
  11. Cardiovascular Disease101 topic
  12. Inflammation101 topic
  13. AIDS81 topic
  14. Vaccine81 topic
  15. Cryptococcal Disease61 topic
  16. Histoplasmosis61 topic
  17. drug use61 topic
  18. harm reduction61 topic
  19. Chronic Hepatitis B51 topic
  20. Dermatophytes51 topic
  21. Hepatitis B Virus51 topic
  22. Onychomycosis51 topic

Where does Samuel Elias Kalluvya work?

Samuel Elias Kalluvya's main affiliation in the publication record is Bugando Medical Centre, Tanzania.

How many publications and citations does Samuel Elias Kalluvya have?

OpenAlex counts 53 works and 948 citations for Samuel Elias Kalluvya, an h-index of 17, ranking #3,224,063 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Samuel Elias Kalluvya. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.